Contraceptive Effectiveness of Sino-implant (II) in China
NCT01936454 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 538
Last updated 2016-02-17
Summary
A cohort study to Evaluate the contraceptive effectiveness of Sino-implant (II) during the 3rd and 4th years of use in Chinese women
Conditions
- Contraception
Sponsors & Collaborators
-
Bill and Melinda Gates Foundation
collaborator OTHER -
FHI 360
lead OTHER
Principal Investigators
-
Markus Steiner, Ph.D. · FHI 360
Eligibility
- Min Age
- 20 Years
- Max Age
- 44 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2015-11-30
- Completion
- 2016-01-31
Countries
- China
Study Locations
More Related Trials
-
Effectiveness of Prolonged Use of IUD/Implant for Contraception
NCT02267616 ·Status: COMPLETED ·Phase: NA
-
Safety of the Etonogestrel-releasing Implant During the Puerperium of Healthy Women
NCT00828542 ·Status: COMPLETED ·Phase: NA
-
The Amenorrhea With Etonogestrel Implant
NCT05040282 ·Status: COMPLETED ·Phase: NA
-
Casea S Contraceptive Implants (Casea S) Trial
NCT05174884 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study to Investigate the Contraceptive Efficacy and Safety of a Subdermal Etonogestrel Implant (Implanon®)(P06473)(COMPLETED)
NCT00725413 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060)
NCT04626596 ·Status: COMPLETED ·Phase: PHASE3
-
the Effect of Implanon on Menstrual Patterns
NCT06936436 ·Status: NOT_YET_RECRUITING
-
A Prospective Observational Study of the Clinical Performance of Femplant in Pakistan
NCT01463254 ·Status: COMPLETED
-
Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles
NCT05139121 ·Status: COMPLETED ·Phase: PHASE3
-
Contraceptive Hormones, Immunity, and Microbiome Evaluation
NCT03660046 ·Status: COMPLETED
-
Hormonal Contraception in Healthy Young Men (P42306)(COMPLETED)(P06057)
NCT00403793 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of Norelgestromine and Ethinyl Estradiol
NCT00307632 ·Status: COMPLETED ·Phase: PHASE4
-
Assessing Ovarian Function During Prolonged Implant Use
NCT03058978 ·Status: COMPLETED
-
Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception
NCT02021097 ·Status: UNKNOWN ·Phase: PHASE3
-
The Influence of Combined Oral Contraception on the DEvelopment and progRession of Chronic venoUs diSeases
NCT04451746 ·Status: COMPLETED ·Phase: NA
-
Long-Acting Reversible Contraception
NCT01299116 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure
NCT02757469 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Effectiveness of NuvaRing® to Prevent Pregnancies in Chinese Women (P06450)
NCT01277211 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive
NCT01963403 ·Status: TERMINATED ·Phase: PHASE4
-
Norethindrone for the Delay of Menstruation
NCT03594604 ·Status: COMPLETED ·Phase: PHASE4
-
Research Study to Investigate the Effect of NNC0174-0833 on a Birth Control Pill in Women Who Are Not Able to Become Pregnant
NCT04074174 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users
NCT02903121 ·Status: COMPLETED ·Phase: PHASE4
-
A Multi-center, Placebo-controlled Study to Evaluate NT100 in Pregnant Women With a History of Unexplained Recurrent Pregnancy Loss (RPL)
NCT02156063 ·Status: UNKNOWN ·Phase: PHASE2
-
The Female Sexual Functions With Progestogen-only Contraception
NCT02579590 ·Status: COMPLETED
-
A Multicenter Trial to Evaluate the Insertion Characteristics of the Radiopaque Etonogestrel Implant Using a Next Generation Applicator (34530)(P05702)
NCT00620035 ·Status: COMPLETED ·Phase: PHASE3